Granite Investment Partners’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
SCM
N
QCM
Granite Investment Partners's NVCR Position: Q3 2025 in Review
Granite Investment Partners sold out of NovoCure (NVCR) in Q3 2025, closing a stake of 604,045 shares — an estimated $10.8M sold.
Granite Investment Partners first reported a position in NVCR in Q2 2018 and held it in 17 quarters. The position peaked at $28.8M in Q3 2018. 245 funds tracked by Wall St. Rank hold NVCR as of Q3 2025.
- Granite Investment Partners reported no remaining NovoCure position as of Q3 2025 after selling out during the quarter.
- Granite Investment Partners sold 604,045 NovoCure shares in Q3 2025, an estimated $10.8M.
- Granite Investment Partners first reported a position in NovoCure in Q2 2018 and held it in 17 quarters.
- Granite Investment Partners's NovoCure position peaked at $28.8M in Q3 2018.
- 245 funds tracked by Wall St. Rank held NovoCure as of Q3 2025.
Based on Granite Investment Partners's 13F filing for Q3 2025, filed 10 Nov 2025.